ADD(603089)
Search documents
正裕工业(603089) - 2025年度向特定对象发行A股股票募集说明书(注册稿)
2026-01-13 08:16
(浙江省玉环市经济开发区正裕路 1 号) 2025 年度向特定对象发行 A 股股票 募集说明书 (注册稿) 保荐机构(主承销商) 广东省广州市黄埔区中新广州知识城腾飞一街 2 号 618 室 联席主承销商 中国(上海)自由贸易试验区商城路 618 号 二〇二五年十二月 股票简称:正裕工业 股票代码:603089 浙江正裕工业股份有限公司 2025 年度向特定对象发行 A 股股票募集说明书 重大事项提示 本公司敬请投资者在作出投资决策前,务必仔细阅读本募集说明书全文,并 特别注意下述重要事项: (一)全球经济持续低迷影响公司经营的风险 声 明 1、本公司及全体董事、高级管理人员承诺募集说明书及其他信息披露资料 不存在任何虚假记载、误导性陈述或重大遗漏,并对其真实性、准确性及完整性 承担相应的法律责任。 2、公司负责人、主管会计工作负责人及会计机构负责人保证募集说明书中 财务会计资料真实、完整。 3、中国证券监督管理委员会、上海证券交易所对本次发行所作的任何决定 或意见,均不表明其对申请文件及所披露信息的真实性、准确性、完整性作出保 证,也不表明其对发行人的盈利能力、投资价值或者对投资者的收益作出实质性 判断或保 ...
正裕工业:向特定对象发行股票申请获证监会同意注册批复
Xin Lang Cai Jing· 2026-01-13 08:13
正裕工业公告称,近日收到中国证监会《关于同意浙江正裕工业股份有限公司向特定对象发行股票注册 的批复》。批复同意公司向特定对象发行股票的注册申请;要求按报送上海证券交易所的申报文件和发 行方案实施;批复自同意注册日起12个月内有效。公司将在规定期限内办理相关事宜,并及时履行信披 义务。 ...
正裕工业:公司管理层始终将股东回报作为核心经营导向
Zheng Quan Ri Bao· 2026-01-09 13:40
(文章来源:证券日报) 证券日报网讯 1月9日,正裕工业在互动平台回答投资者提问时表示,公司管理层始终将股东回报作为 核心经营导向,通过聚焦核心主业深耕,优化业务结构布局,强化产业链上下游协同效应,持续提升市 场核心竞争力与盈利质量。公司将在巩固和提升现有业务的基础上,持续关注行业发展趋势,积极探索 相关延伸领域,为股东创造长期、稳定且可预期的投资价值。 ...
密集公告:重大资产重组
Shang Hai Zheng Quan Bao· 2025-12-17 16:12
Group 1: Major Asset Restructuring - Pulutong plans to acquire 100% of Leqee Group Limited and 8.26% of Hangzhou Lemai through share issuance and cash payment, with the transaction price yet to be determined [2][3] - Wanlong Optoelectronics intends to acquire 100% of Zhejiang Zhongkong Information Industry Co., Ltd. through share issuance and cash payment, with the final transaction price still pending [4][5] - Fengxing Co. plans to acquire 75% of Baiyin Huaxin Jiuhe Recycling Resources Co., Ltd. through share issuance and cash payment, with the asset valuation and transaction price yet to be confirmed [6] Group 2: Corporate Mergers and Acquisitions - CICC disclosed a plan to absorb and merge Dongxing Securities and Xinda Securities, with the merger expected to result in the cancellation of the latter's listings [7] - Meike Home is in the process of planning to acquire control of Shenzhen Wandelong Optoelectronics Co., Ltd., with the valuation still under consideration [8] Group 3: Significant Contracts and Agreements - China CRRC signed several major contracts totaling approximately 533.1 billion yuan, which includes contracts for wind power equipment and urban rail vehicles [15] - China Duty Free Group won bids for duty-free store projects at Shanghai Pudong and Hongqiao International Airports, with a joint investment of 102 million yuan for a new duty-free joint venture [16]
正裕工业:控股股东及一致行动人减持计划时间届满暨减持结果的公告
Zheng Quan Ri Bao Zhi Sheng· 2025-12-17 12:41
证券日报网讯 12月17日晚间,正裕工业发布公告称,本次减持计划实施前,公司实际控制人郑连松直 接持有公司股份16,511,904股,占公司总股本的比例6.88%。截至本公告披露日,减持计划的减持时 间区间已届满,在减持计划实施期间内,郑连松投资通过集中竞价交易方式减持公司2,000,000股股 份,占公司目前总股本0.83%。 (编辑 任世碧) ...
12月17日晚间重要公告一览
Xi Niu Cai Jing· 2025-12-17 10:21
Group 1 - CICC is planning to absorb and merge Dongxing Securities and Xinda Securities through a share swap, with trading resuming on December 18, 2025 [1] - Victory Energy's major shareholder plans to transfer 29.99% of its shares to Qiteng Robotics, with no plans for asset restructuring in the next 12 months [2] - China Metallurgical Group intends to repurchase A-shares worth 1 to 2 billion yuan at a price not exceeding 4.9 yuan per share [3] Group 2 - Boten Co. plans to acquire part of the Yifeng Yunding Fund for 1 yuan, with a commitment to fulfill a 20 million yuan capital contribution [4] - Tongyou Technology has initiated a 50 million yuan accounts receivable factoring business [5] - Gaode Infrared has received approval to issue debt financing tools totaling up to 3 billion yuan [6] Group 3 - Zhengyu Industrial's application for a private placement of A-shares has been approved by the Shanghai Stock Exchange [7] - China CRRC signed contracts totaling approximately 53.31 billion yuan, accounting for 21.6% of its projected 2024 revenue [9] - High Energy Environment's director increased his stake by purchasing 56,100 shares [10] Group 4 - Shantou Technology received approval from the CSRC for a convertible bond issuance [11] - Puyang Co. plans to use up to 900 million yuan of idle funds for entrusted wealth management [12] - Huibai New Materials has been awarded a government subsidy of 3.8 million yuan, with the first installment of 2.12 million yuan already received [13] Group 5 - Jiayuan Technology's shareholders plan to transfer 2.51% of the company's shares through a pricing inquiry [14] - Lingpai Technology's subsidiary terminated a 125 million yuan procurement contract due to market changes [15] - Juguang Technology intends to use up to 200 million yuan of idle funds for cash management [16] Group 6 - Zhongwen Media's subsidiary terminated a 200 million yuan private equity fund subscription due to market changes [17] - Zhifei Biological's modified vaccine for monkeypox has received clinical trial acceptance [19] - GeKowei's subsidiary received a government subsidy of 60 million yuan, accounting for 32.12% of the company's audited net profit [20] Group 7 - Wantai Biological's application for a clinical trial of a respiratory syncytial virus vaccine has been accepted [21] - Haitai Technology plans to increase capital in its Thai joint venture from 500,000 to 3 million Thai baht [22] - Shanghai Airport signed contracts for the transfer of duty-free store operating rights [23] Group 8 - Del Shares received approval to issue shares for the acquisition of 100% of Aizhuo Intelligent [24] - Novozymes' products have obtained EU CE IVDR certification [25] - Shibai Testing's chairman's assistant plans to increase shareholding by 8 to 12 million yuan [26] Group 9 - Huitian New Materials plans to invest approximately 97.68 million yuan in a lithium battery anode glue project [27] - Pudong Construction's subsidiaries won contracts totaling 1.649 billion yuan [29] - Acolyte's subsidiary has entered trial production for a special high-temperature resistant resin project [30] Group 10 - Pingzhi Information's subsidiary signed a 38.25 million yuan computing power service contract [31] - Tianma Technology is required to pay 5.3625 million yuan in taxes and penalties [32] - Yahon Pharmaceutical's clinical trial application for GLX002 has been approved [34]
正裕工业:非公开发行股票申请获得上交所审核通过
Mei Ri Jing Ji Xin Wen· 2025-12-17 09:31
截至发稿,正裕工业市值为30亿元。 每经头条(nbdtoutiao)——"太空快递"来了?全国首个民营飞船成功"上天"!背后公司创始人:正积 极开发"中型货运飞船"低成本产品 (记者 张明双) 每经AI快讯,正裕工业(SH 603089,收盘价:12.48元)12月17日晚间发布公告称,公司于2025年12月 16日收到上海证券交易所出具的《关于浙江正裕工业股份有限公司向特定对象发行股票的交易所审核意 见》,具体意见如下:"浙江正裕工业股份有限公司向特定对象发行股票申请符合发行条件、上市条件 和信息披露要求。本所将在收到你公司申请文件后提交中国证监会注册。" 2024年1至12月份,正裕工业的营业收入构成为:汽车零部件占比99.74%,其他业务占比0.26%。 ...
正裕工业(603089) - 关于向特定对象发行A股股票申请获得上海证券交易所审核通过的公告
2025-12-17 09:30
证券代码:603089 证券简称:正裕工业 公告编号:2025-090 "浙江正裕工业股份有限公司向特定对象发行股票申请符合发行条件、上市 条件和信息披露要求。本所将在收到你公司申请文件后提交中国证监会注册。" 公司本次向特定对象发行 A 股股票事项尚需中国证券监督管理委员会(以下 简称"中国证监会")做出同意注册的决定后方可实施。最终能否获得中国证监 会同意注册的决定及其时间尚存在不确定性。公司将根据事项的进展情况,按照 相关法律法规要求及时履行信息披露义务,敬请广大投资者注意投资风险。 特此公告。 浙江正裕工业股份有限公司董事会 2025 年 12 月 18 日 浙江正裕工业股份有限公司 关于向特定对象发行 A 股股票申请获得上海证券交易所审核 通过的公告 " 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏,并对其内容的真实性、准确性和完整性承担个别及连带责任。 浙江正裕工业股份有限公司(以下简称"公司")于 2025 年 12 月 16 日收 到上海证券交易所出具的《关于浙江正裕工业股份有限公司向特定对象发行股票 的交易所审核意见》,具体意见如下: ...
正裕工业(603089.SH):实际控制人郑连松已减持200万股股份
Ge Long Hui A P P· 2025-12-17 09:18
格隆汇12月17日丨正裕工业(603089.SH)公布,截止本公告披露日,减持计划的减持时间区间已届满, 在减持计划实施期间内,郑连松投资通过集中竞价交易方式减持公司200万股股份,占公司目前总股本 0.83%。 ...
正裕工业(603089) - 控股股东及一致行动人减持计划时间届满暨减持结果的公告
2025-12-17 09:17
大股东持股的基本情况 本次减持计划实施前,浙江正裕工业股份有限公司(以下简称"公司")实 际控制人郑连松直接持有公司股份 16,511,904 股,占公司总股本的比例 6.88%。 减持计划的实施结果情况 公司于 2025 年 8 月 28 日在上海证券交易所网站(www.sse.com.cn)披露了 《浙江正裕工业股份有限公司控股股东及一致行动人减持股份计划公告》 (公 告编号:2025-072),郑连松拟于本减持计划公告披露之日起 15 个交易日后的 3 个月内,以集中竞价方式减持其持有的公司股份不超过 2,400,332 股,即不超 过公司股份总数的 1.00%。 截止本公告披露日,减持计划的减持时间区间已届满,在减持计划实施期间 内,郑连松投资通过集中竞价交易方式减持公司 2,000,000 股股份,占公司目前 总股本 0.83%。 证券代码:603089 证券简称:正裕工业 公告编号:2025-091 浙江正裕工业股份有限公司 控股股东及一致行动人减持计划时间届满 暨减持结果的公告 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏,并对其内容的真实性、准确性 ...